These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6688732)

  • 41. Estimation of 13, 14-dihydro-15-keto-prostaglandin F2 alpha (PGF2 alpha M) in patients with endometriosis.
    Wang YF; Han ML; Sun AD; Huang RL; Zhang H; Ma XH; Cheng JX; Duan JH
    Proc Chin Acad Med Sci Peking Union Med Coll; 1987; 2(2):107-10. PubMed ID: 3423006
    [No Abstract]   [Full Text] [Related]  

  • 42. Role of prostaglandins E1, E2, F2 alpha, I2 and thromboxane in salmonella-associated arthritis in rats.
    Karmali RA; Davies J; Volkman A
    Prostaglandins Leukot Med; 1982 May; 8(5):437-46. PubMed ID: 7048334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma prostaglandin levels in radiation-induced enteritis.
    Lifshitz S; Savage JE; Taylor KA; Tewfik HH; Van Orden DE
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):275-7. PubMed ID: 7085382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of 13,14-dihydro-15-oxo-prostaglandin F2 alpha in the circulation during infusions of bradykinin and prostaglandin E2 in man.
    Barrow SE; Cockcroft J; Dollery CT; Hickling NE; Ritter JM
    Br J Pharmacol; 1987 May; 91(1):245-50. PubMed ID: 3474045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gas chromatography-mass spectrometry of some prostanoids with new derivatizing agents. Application to the analysis of 13,14-dihydro-15-ketoprostaglandin F2 alpha.
    Yamashita K; Watanabe K; Ishibashi M; Miyazaki H; Yokota K; Horie K; Yamamoto S
    J Chromatogr; 1987 Jul; 399():223-34. PubMed ID: 3654856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in plasma oxytocin, prostaglandin E1, and 13,14-dihydro-15-keto-prostaglandin F2 alpha during labor induced by prostaglandin E2 or F2 alpha and spontaneous labor.
    Nagata I; Seki K; Uesato T; Sunaga H; Furuya K; Makimura N; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Sep; 39(9):1627-33. PubMed ID: 3479503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostaglandin F2 alpha and prostacyclin imbalance in cows with placental retention: new findings.
    Horta AE; Chassagne M; Brochart M
    Ann Rech Vet; 1986; 17(4):395-400. PubMed ID: 3548561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endotoxin-induced hypotension and blood levels of 6-keto-prostaglandin F1 alpha.
    Bult H; Beetens J; Vercruysse P; Herman AG
    Adv Prostaglandin Thromboxane Res; 1980; 7():839-41. PubMed ID: 6768233
    [No Abstract]   [Full Text] [Related]  

  • 49. The safety of fetoscopy: (II). Effect on maternal plasma levels of 13,14-dihydro-15-oxo-prostaglandin F2 alpha.
    Nicolaides KH; Koullapis EN; Rodeck CH
    Prenat Diagn; 1983; 3(2):97-100. PubMed ID: 6622402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostaglandin F2 alpha in benign and malignant breast tumours.
    Vergote IB; Laekeman GM; Keersmaekers GH; Uyttenbroeck FL; Vanderheyden JS; Albertyn GP; Haensch CF; De Roy GJ; Herman AG
    Br J Cancer; 1985 Jun; 51(6):827-36. PubMed ID: 3859318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma levels of 15-keto-13,14-dihydroprostaglandin F2 alpha in primiparous lactating sows.
    Kunavongkrit A; Srisakwattana K; Kindahl H
    Acta Vet Scand; 1984; 25(1):148-50. PubMed ID: 6464921
    [No Abstract]   [Full Text] [Related]  

  • 52. Peripheral plasma immunoreactive 6-oxo-prostaglandin F1 alpha and gynaecological tumours.
    Alam M; Jogee M; MacGregor WG; Dowdell JW; Elder MG; Myatt L
    Br J Cancer; 1982 Mar; 45(3):384-9. PubMed ID: 6896152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aminoglutethimide as an aromatase inhibitor in the treatment of cancer.
    Santen RJ
    Cancer Treat Rev; 1984 Dec; 11(4):325-9. PubMed ID: 6534513
    [No Abstract]   [Full Text] [Related]  

  • 54. Relative concentration of 13,14-dihydro-15 ketoprostaglandin F-2 alpha in blood and milk of buffaloes during the oestrous cycle and early pregnancy.
    Batra SK; Pandey RS
    J Reprod Fertil; 1983 Jan; 67(1):191-5. PubMed ID: 6822972
    [No Abstract]   [Full Text] [Related]  

  • 55. Calcitonin temporarily increases 6-oxo-prostaglandin F1 alpha-levels in man.
    Sinzinger H; Peskar BA; Clopath P; Kovarik J; Burghuber O; Silberbauer K; Leithner C; Woloszczuk W
    Prostaglandins; 1980 Oct; 20(4):611-2. PubMed ID: 6894034
    [No Abstract]   [Full Text] [Related]  

  • 56. Radioimmunoassay of the major plasma metabolite of PGF2 alpha, 15-keto-13,14-dihydro-PGF2 alpha.
    Granström E; Kindahl H
    Methods Enzymol; 1982; 86():320-39. PubMed ID: 6957702
    [No Abstract]   [Full Text] [Related]  

  • 57. Identification of a 'urinary-type' metabolite of prostaglandin F2 alpha in the rat circulation.
    Edwards NS; Pace-Asciak CR
    Biochim Biophys Acta; 1982 May; 711(2):369-71. PubMed ID: 6953981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relevance of urinary 6-keto-prostaglandin F1 alpha determination.
    Rosenkranz B; Kitajima W; Frölich JC
    Kidney Int; 1981 Jun; 19(6):755-9. PubMed ID: 7021952
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: Medical adrenalectomy with aminoglutethimide.
    Corder MP; Flannery EP
    JAMA; 1975 Sep; 233(10):1047-8. PubMed ID: 1174144
    [No Abstract]   [Full Text] [Related]  

  • 60. Rapid solid-phase immunoassay for 6-keto prostaglandin F1 alpha on microplates.
    Schramm W; Smith RH; Jackson TM; Craig PA; Grates HE; Minton LL
    Clin Chem; 1990 Mar; 36(3):509-14. PubMed ID: 2311222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.